The Public Face of Sulzer Medica
Executive SummarySulzer Medica is one of Europe's leading medical device firms. But during the 1990s, though it grew nicely, it still trailed other, US-based multi-national device firms. That was because the company had struggled with product development and had no publicly-traded stock with which to acquire new businesses. Now fresh from a successful IPO, Suler is ready to play by a whole new set of rules.
You may also be interested in...
The Chinese government's plan to reduce tariffs it imposed on a slew of US exports is expected to have minimal impact on the overall medtech industry. See what Ralph Ives, AdvaMed's executive VP for global strategy, said about it here.